NCT00000973View on ClinicalTrials.gov

A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1995

Conditions
Toxoplasmosis, CerebralHIV Infections
Interventions
DRUG

Pyrimethamine

DRUG

Leucovorin calcium

DRUG

Zidovudine

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Ctr., New York

27599

Unc Aids Crs, Chapel Hill

Sponsors

Collaborators (1)

Glaxo Wellcome
All Listed Sponsors
collaborator

Glaxo Wellcome

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH